EXTRA STRENGTH MIDOL 32.4 MG
CAFFEINE : 32.4 MG ACETYLSALICYLIC ACID : 500 MG · DIN 02217732 · BAYER INC CONSUMER CARE
Health Canada status: CANCELLED POST MARKET
What is EXTRA STRENGTH MIDOL?
EXTRA STRENGTH MIDOL 32.4 MG contains CAFFEINE : 32.4 MG ACETYLSALICYLIC ACID : 500 MG. It is listed in the Health Canada Drug Product Database under DIN 02217732, held by BAYER INC CONSUMER CARE, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 02-Aug-2007. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02217732 |
|---|---|
| Brand name | EXTRA STRENGTH MIDOL |
| Generic / active ingredient | CAFFEINE : 32.4 MG ACETYLSALICYLIC ACID : 500 MG |
| Manufacturer | BAYER INC CONSUMER CARE |
| Strength | 32.4 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | N02BA51 ACETYLSALICYLIC ACID, COMB EXCL PSYCHOLEPTICS |
| AHFS class | 28:08.04.24 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 02-Aug-2007 |
| Original market date | 1996-10-01 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02217732 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2217732 |
| Brand name | EXTRA STRENGTH MIDOL |
| Active ingredient / INN | CAFFEINE : 32.4 MG ACETYLSALICYLIC ACID : 500 MG |
| ATC code | N02BA51 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N02 |
| AHFS class | 28:08.04.24 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | BAYER INC CONSUMER CARE |
Which pack is which?
| Strength on the label | 32.4 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code N02BA51 ACETYLSALICYLIC ACID, COMB EXCL PSYCHOLEPTICS. 0 of 54 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| 217 | 325 MG | TABLET | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | CANCELLED POST MARKET | DIN 00666645 |
| 217 STRONG TAB | 30 MG | TABLET | MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | CANCELLED POST MARKET | DIN 00259802 |
| ALKA SELTZER EVT | 1.916 G | TABLET (EFFERVESCENT) | MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION | CANCELLED POST MARKET | DIN 00623008 |
| ALKA SELTZER FLAVOURED | 1.71 G | TABLET (EFFERVESCENT) | MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION | CANCELLED POST MARKET | DIN 00709077 |
| ALKA SELTZER PLUS COLD MEDICINE EVT | 325 MG | TABLET (EFFERVESCENT) | MILES CANADA INC. - CONSUMER HEALTH CARE DIVISION | CANCELLED POST MARKET | DIN 01919261 |
| ALKA-SELTZER | 1000 MG | TABLET (EFFERVESCENT) | BAYER INC | CANCELLED POST MARKET | DIN 02152746 |
| ALKA-SELTZER FLAVOURED | 1700 MG | TABLET (EFFERVESCENT) | BAYER INC | CANCELLED POST MARKET | DIN 02245367 |
| ALKA-SELTZER FLAVOURED - EVT | 325 MG | TABLET (EFFERVESCENT) | BAYER INC CONSUMER CARE | CANCELLED POST MARKET | DIN 02152754 |
| ALKA-SELTZER MORNING RELIEF | 500 MG | TABLET (EFFERVESCENT) | BAYER INC CONSUMER CARE | CANCELLED POST MARKET | DIN 02244451 |
| ALKA-SELTZER PLUS COLD MEDICINE - EVT | 24.1 MG | TABLET (EFFERVESCENT) | BAYER INC CONSUMER CARE | CANCELLED POST MARKET | DIN 02152800 |
Who else supplies ACETYLSALICYLIC ACID, COMB EXCL PSYCHOLEPTICS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ACETYLSALICYLIC ACID, COMB EXCL PSYCHOLEPTICS appears in 11 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.